Reduced levels of SMN due to mutations or deletions of the SMN1 gene cause the common neurodegenerative disorder spinal muscular atrophy (SMA), the leading genetic cause of infant mortality worldwide, which affects approximately one in 6,000 infants. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.